Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multinational, Randomized, Open Label Parallel Arm Trial With Blinded Outcome Adjudication Quantifying the Efficacy of SENATOR in Reducing Adverse Drug Reactions in Older Hospitalized Subjects

NCT02097654 is registered in ClinicalTrials.gov with University College Cork as lead sponsor.

NCT NCT02097654
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02097654 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multinational, Randomized, Open Label Parallel Arm Trial With Blinded Outcome Adjudication Quantifying the Efficacy of SENATOR in Reducing Adverse Drug Reactions in Older Hospitalized Subjects
Lead sponsor
University College Cork
Phase
Not applicable
Overall status
Completed
Start date
July 9, 2014
Completion date
June 30, 2018
Enrollment
1,537 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adverse drug reactions